ESD for Colorectal LSL Using a Selective Strategy - a Prospective Cohort Study
Recruiting
N/A
Interventional Study
Colorectal Neoplasm
Endoscopic Mucosal Resection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 391 (estimated)
- Sponsor
- Western Sydney Local Health District · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Colonic Laterally spreading lesions (LSL) =\> 20mm are at high risk to progress to cancer. Overt stigmata of submucosal invasive cancer (SMIC) has been well characterized and includes ulceration and surface pit pattern changes as per the Kudo classification of type V.
In a recent report, risk factors for LSL with SMIC and no overt stigmata (i.e. covert SMIC) were described. Resection of these les…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* All patients referred for colorectal resection of large laterally spreading lesions in colon.
* Can give informed consent to trial participation
Exclusion Criteria:
* Previous resection or attempted resection of target adenoma lesion
* Endoscopic appearance of invasive malig…
Contacts